Genmab — Marts 2020
-
U.S.-LISTED SHARES OF BIONTECH SE UP 60.4% PREMARKET AFTER CO TO DEVELOP POTENTIAL COVID-19 VACCINE WITH PFIZER - Reuters News
-
De har deres platform, der kan generere tusinder af antistoffer om ugen, som JW lirer af gang på gang. Jeg ved jo at deres medarbejdere har rodet med ebola etc. Så helt tabt er de ikke. Men nej ikke overraskende og sikkert også noget der alt for sent bliver færdig til brug.
-
even though Curevac is acting a bit weird... https://www.evaluate.com/vantage/articles/news/policy-and-regulation/crisis-what-crisis-curevac-denies-everything
-
A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemia - Blood advances
-
" The Irish Times ". Stocktake : Foolish Trump hit by market collapse. https://www.irishtimes.com/business/personal-finance/stocktake-foolish-trump-hit-by-market-collapse-1.4202227
-
Successful treatment of thrombocytopenia with daratumumab after allogeneic transplant: a case report and literature review https://ashpublications.org/bloodadvances/article/4/5/815/452582/Successful-treatment-of-thrombocytopenia-with
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind